SINTX clears Nasdaq's equity test with $4.83 million, a cushion its own burn rate could erase in a quarter

by Renée Delacroix · August 14, 2026

Senior Analyst, The MicroCap Herald

SINTX Technologies, Inc. (Nasdaq: SINT) said on Thursday, August 13 that it had received written confirmation from Nasdaq that it has regained compliance with Listing Rule 5550(b)(1), the continued-listing standard requiring Nasdaq Capital Market companies to maintain stockholders' equity of at least $2.5 million. The determination was based on the company's Form 10-Q for the quarter ended June 30, 2026, which reported stockholders' equity of approximately $4.83 million.

The deficiency it resolves was recent and substantial. SINTX disclosed that Nasdaq notified it on May 22, 2026 that it no longer satisfied the rule, having reported stockholders' equity of approximately $904,000 as of March 31, 2026 — roughly $1.6 million short of the threshold. The company also did not meet either of the alternative continued-listing standards, the market value of listed securities test or the net income test, and was given until July 6, 2026 to submit a remediation plan.

Eric K. Olson, SINTX's chairman and chief executive, said in the company's announcement: "We are pleased to have resolved this matter and to have Nasdaq confirm our compliance with the minimum stockholders' equity requirement." The Herald quotes only the wording it could verify verbatim across the release and independent reports of it.

The process behind that letter is worth spelling out because it defines what happens if the equity slips again. As a summary published by law firm Honigman describes, a company receiving a stockholders' equity deficiency notice has 45 calendar days to submit a compliance plan; if Nasdaq accepts it, the company may receive an extension of up to 180 calendar days from the date of the notice, and the plan must show equity exceeding $2.5 million within that window along with projections demonstrating compliance through the following four quarters. Failure within the allotted time produces a delisting notice, appealable to a Hearings Panel.

SINTX cleared the bar by raising capital rather than by earning it. On June 3, 2026 the company announced approximately $5.0 million of capital, comprising a $4.5 million private placement priced at-the-market under Nasdaq rules plus roughly $0.5 million previously drawn through its at-the-market program. The placement sold 1,882,845 shares at a combined effective price of $2.39 per share and accompanying warrants, together with Class A warrants over 1,882,845 shares and Class B warrants over a further 1,882,845 shares, both exercisable immediately at $2.14 per share. The Class A warrants expire five years from issuance and the Class B warrants two years. Proceeds were designated for general corporate purposes, working capital, commercialization and business development.

A note on basis, because this company has restructured its share count: all figures in this article are stated on the post-split basis established by SINTX's 1-for-200 reverse stock split effective at 12:01 a.m. Eastern on May 28, 2024, which reduced shares outstanding from approximately 123 million to approximately 0.6 million and was undertaken to address the minimum bid price rule. No pre-split figures appear here. On that basis, the company's second-quarter 10-Q reports 6,613,065 shares of common stock outstanding as of June 30, 2026.

The warrant overhang against that count is material. The June placement alone created 3,765,690 warrant shares at $2.14. Separately, an 8-K covering actions dated June 29, 2026 discloses that SINTX cancelled a holder's existing September 2025 warrant over 760,881 shares and issued a replacement warrant over 1,268,135 shares at $2.14, exercisable for five years in cash or, if no effective registration statement is available after 90 days, by cashless exercise. The same filing shows 507,254 shares previously held in abeyance resolved into 255,267 shares of common stock and a pre-funded warrant over 251,987 shares exercisable on a cashless basis. Both instruments carry a 9.99% beneficial ownership limitation, and the filing states that the replacement warrant's exercise price is subject to full-ratchet downward adjustment in any dilutive equity financing, subject to stockholder approval to the extent required by Nasdaq Listing Rule 5635(d). Added together, the disclosed warrant overhang is 5,285,812 shares against 6,613,065 shares outstanding.

A full-ratchet provision is the sharpest form of anti-dilution protection and deserves plain description: if the company later issues equity below the warrant's exercise price, the exercise price resets down to that lower price, increasing the number of shares issuable for the same cash and transferring value from existing holders. The 8-K uses that term expressly. Given that SINTX has raised capital repeatedly, the clause is not theoretical.

The operating figures show why further raises are the base case. SINTX reported second-quarter revenue of approximately $452,000, with six-month revenue of $832,000, against a second-quarter net loss of $2.7 million and a six-month net loss of $5.5 million. Cash and equivalents were $3.6 million at June 30, 2026 against total assets of $10.43 million, and the accumulated deficit stood at approximately $297.6 million. The company took in $4.5 million of gross proceeds from the June private placement and $1.3 million through its at-the-market programme in the first half, with $5.1 million of capacity remaining under the ATM.

The going-concern language has not been withdrawn. In the same second-quarter 10-Q on which Nasdaq based its compliance determination, management stated that substantial doubt remains regarding the company's ability to continue as a going concern for a period of at least twelve months from the date the condensed consolidated financial statements are issued. That is a second-quarter disclosure, not a first-quarter one carried forward. Regaining compliance with a listing standard and resolving a going-concern qualification are separate questions, and only the first has been answered.

The arithmetic of the cushion is the point readers should hold onto. Stockholders' equity of approximately $4.83 million sits about $2.33 million above the $2.5 million minimum. The company's second-quarter net loss was approximately $2.7 million. Absent new capital, revenue growth of a different order, or non-cash items working in the company's favour, a single quarter of losses at that rate would consume the entire margin above the threshold — which is precisely how a company arrives back where SINTX was in May. Any equity raised to prevent that outcome would itself be dilutive, and any raise priced below $2.14 would engage the full-ratchet term on the replacement warrant, resetting its exercise price downward and increasing the shares issuable under it.

Two things the Thursday announcement did not do are worth recording. It did not reference the minimum bid price rule, Listing Rule 5550(a)(2), and it did not disclose any post-compliance monitoring arrangement; readers should not infer either way from its silence. Separately, the Herald found materially inconsistent share-price and market-capitalisation data for SINT across providers on Thursday and is therefore not citing a price or market value in this article — a recurring hazard in this size band that is itself worth knowing about, and one reason the market value of listed securities alternative under Rule 5550(b)(2) is not a reliable fallback to assume.

For context, Thursday was a record session for the S&P 500, which rose 0.7% to 7,798.99 and topped its prior all-time high; the Russell 2000 closed at 3,052.85, up 7.36 points or 0.2%, according to the Associated Press tally of the day's closes; both indexes set record closes, as Schaeffer's Investment Research reported. The Russell 2000 is a small-cap index rather than a micro-cap proxy, and its level tells a reader nothing about the position of a company that spent the spring below a $2.5 million equity floor. The next test for SINTX is mechanical: the stockholders' equity line in its third-quarter 10-Q.